Earnings up, expectations down: UnitedHealth’s Q1 in review

ByInvestment Club

Overview

UnitedHealth Group posted strong top-line growth in the first quarter of 2025, supported by increased customer reach across its UnitedHealthcare and Optum businesses. However, despite revenue and earnings gains, the company revised its full-year outlook downward, citing unexpected Medicare-related care activity and reimbursement dynamics.

CEO Andrew Witty acknowledged the shortfall: “We grew to serve more people more comprehensively but did not perform up to our expectations.”

Q1 2025 vs. Q1 2024:

  • Revenue increased to a record value of $109.6bn (+9.8% YoY), driven by broader service coverage and higher engagement across business lines.
    • UnitedHealthcare revenue was $84.6bn (+12.2% YoY), impacted by higher-than-expected care activity levels within UnitedHealthcare’s Medicare Advantage business.
    • Optum revenue grew to $63.9bn (+4.6% YoY), led by Optum Rx, with the strong growth driven by new clients served as well as expanded relationships with existing clients.
  • Operating income recorded a value of $9.1bn (+15.2% YoY), fueled by margin improvements and scale efficiencies.
    • UnitedHealthcare operating income increased to $5.2bn (+18.2% YoY), while Optum operating income was $3.9bn (+11.4% YoY).
  • Net earnings per share (EPS) was $6.85 (vs. -$1.53 in Q1 2024), a return to profitability after 2024’s Brazil-related write-off. Adjusted EPS grew to a value of $7.20 (+4.2% YoY).
  • Operating margin was 8.3% (vs. 7.9% in Q1 2024), despite elevated medical care ratio (84.8% vs. 84.3%).
  • Cash flows from operations for the first quarter were $5.5bn (compared to $1.1bn in Q1 2024).
  • During the first quarter 2025, the company returned nearly $5bn to shareholders through dividends and share repurchases.
  • ROE of 26.8% in the first quarter, reflected the company’s consistent, broad-based earnings and efficient capital structure.

UnitedHealth Group revised its full-year 2025 outlook to account for elevated care costs and changes in member profiles, particularly within its Medicare Advantage business. The company now expects net earnings per share in the range of $24.65 to $25.15, and adjusted earnings per share between $26.00 and $26.50, reflecting a slight downward revision from previous estimates. Despite these short-term headwinds, UnitedHealth remains confident in its ability to address current challenges and is reaffirming its long-term annual EPS growth target of 13% to 16%, starting in 2026.

After a good period on the US market, in which the UNH share price has actually been on an upward slope since mid-February, trading just above the 50-day moving average and in overbought zones according to the RSI indicator, the company’s stock price collapsed at the end of this week, falling by more than -22% in a single day, after the downward outlook for 2025 results. The price fell below the 50-day moving average again, indicating negative sentiment from investors, who quickly priced in the downward estimates announced by the company’s management.

Source: TradingView

Author: Ionuț-Adrian Lazar

Similar Posts